Morgan Stanley Reiterates Overweight on iRhythm Technologies, Maintains $149 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong has reiterated an 'Overweight' rating on iRhythm Technologies (NASDAQ:IRTC) and maintained a price target of $149.
August 04, 2023 | 6:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reiterated an 'Overweight' rating on iRhythm Technologies, indicating a positive outlook for the company's stock.
Analyst ratings often influence investor sentiment and can impact a company's stock price. An 'Overweight' rating suggests that the analyst believes the company's stock will outperform the market, which could lead to an increase in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100